BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ruiz-Calvo A, Bajo-Grañeras R, Maroto IB, Zian D, Grabner GF, García-Taboada E, Resel E, Zechner R, Zimmermann R, Ortega-Gutiérrez S, Galve-Roperh I, Bellocchio L, Guzmán M. Astroglial monoacylglycerol lipase controls mutant huntingtin-induced damage of striatal neurons. Neuropharmacology 2019;150:134-44. [PMID: 30914306 DOI: 10.1016/j.neuropharm.2019.03.027] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Rivas-Santisteban R, Lillo J, Raïch I, Muñoz A, Lillo A, Rodríguez-Pérez AI, Labandeira-García JL, Navarro G, Franco R. The cannabinoid CB(1) receptor interacts with the angiotensin AT(2) receptor. Overexpression of AT(2)-CB(1) receptor heteromers in the striatum of 6-hydroxydopamine hemilesioned rats. Exp Neurol 2023;362:114319. [PMID: 36632949 DOI: 10.1016/j.expneurol.2023.114319] [Reference Citation Analysis]
2 Stella N. THC and CBD: Similarities and differences between siblings. Neuron 2023:S0896-6273(22)01119-9. [PMID: 36638804 DOI: 10.1016/j.neuron.2022.12.022] [Reference Citation Analysis]
3 Bernal-Chico A, Tepavcevic V, Manterola A, Utrilla C, Matute C, Mato S. Endocannabinoid signaling in brain diseases: Emerging relevance of glial cells. Glia 2023;71:103-26. [PMID: 35353392 DOI: 10.1002/glia.24172] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Costas-Insua C, Guzmán M. Endocannabinoid signaling in glioma. Glia 2023;71:127-38. [PMID: 35322459 DOI: 10.1002/glia.24173] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Martinez Ramirez CE, Ruiz‐pérez G, Stollenwerk TM, Behlke C, Doherty A, Hillard CJ. Endocannabinoid signaling in the central nervous system. Glia 2022. [DOI: 10.1002/glia.24280] [Reference Citation Analysis]
6 Ramon-Duaso C, Conde-Moro AR, Busquets-Garcia A. Astroglial cannabinoid signaling and behavior. Glia 2022. [PMID: 35293647 DOI: 10.1002/glia.24171] [Reference Citation Analysis]
7 Paredes-Ruiz KJ, Chavira-Ramos K, Orozco-Morales M, Karasu C, Tinkov AA, Aschner M, Santamaría A, Colín-González AL. On the Biomedical Properties of Endocannabinoid Degradation and Reuptake Inhibitors: Pre-clinical and Clinical Evidence. Neurotox Res 2021. [PMID: 34741755 DOI: 10.1007/s12640-021-00424-z] [Reference Citation Analysis]
8 Deng L, Viray K, Singh S, Cravatt B, Stella N. ABHD6 Controls Amphetamine-Stimulated Hyperlocomotion: Involvement of CB1 Receptors. Cannabis Cannabinoid Res 2021. [PMID: 34705543 DOI: 10.1089/can.2021.0066] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Zanfirescu A, Ungurianu A, Mihai DP, Radulescu D, Nitulescu GM. Targeting Monoacylglycerol Lipase in Pursuit of Therapies for Neurological and Neurodegenerative Diseases. Molecules 2021;26:5668. [PMID: 34577139 DOI: 10.3390/molecules26185668] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
10 Pérez-Olives C, Rivas-Santisteban R, Lillo J, Navarro G, Franco R. Recent Advances in the Potential of Cannabinoids for Neuroprotection in Alzheimer's, Parkinson's, and Huntington's Diseases. Adv Exp Med Biol 2021;1264:81-92. [PMID: 33332005 DOI: 10.1007/978-3-030-57369-0_6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
11 Novosadova E, Antonov S, Arsenyeva E, Kobylanskiy A, Vanyushina Y, Malova T, Khaspekov L, Bobrov M, Bezuglov V, Tarantul V, Illarioshkin S, Grivennikov I. Neuroprotective and neurotoxic effects of endocannabinoid-like compounds, N-arachidonoyl dopamine and N-docosahexaenoyl dopamine in differentiated cultures of induced pluripotent stem cells derived from patients with Parkinson's disease. Neurotoxicology 2021;82:108-18. [PMID: 33248189 DOI: 10.1016/j.neuro.2020.11.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Lourenço DM, Ribeiro-Rodrigues L, Sebastião AM, Diógenes MJ, Xapelli S. Neural Stem Cells and Cannabinoids in the Spotlight as Potential Therapy for Epilepsy. Int J Mol Sci 2020;21:E7309. [PMID: 33022963 DOI: 10.3390/ijms21197309] [Reference Citation Analysis]
13 Herranz-Herrer J, Gil-Benito E, Ponte-López T, Ortega-Gutiérrez S, Macicior J, Rosado-Garcia S, Sánchez-López AJ, Blasco-Fontecilla H. Serum endocannabinoid levels in suicide attempters: A pilot study. Eur Neuropsychopharmacol 2020;40:52-60. [PMID: 32994115 DOI: 10.1016/j.euroneuro.2020.09.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]